1-20 of 135
Stefan O. Ciurea
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Tolerability of BCMA-Directed mRNA CAR T-Cell Therapy in Multiple Myeloma and Autoimmune Disease

Milos D Miljkovic, Adam S. Asch, Gregory Orloff, Ralph Boccia, Jesús G Berdeja, Fevzi Altuntas, Stefan O. Ciurea, James F Howard, Jr., Tuan Vu, Bennett Myers, Nizar Chahin, Tahseen Mozaffar, Christopher M Jewell, Metin Kurtoglu
Journal: Blood
Blood (2024) 144 (Supplement 1): 2080.
https://doi.org/10.1182/blood-2024-203585
Published: 2024
Journal Articles

Final Results of a Prospective Observational Study Using Budesonide, Added to Ptcy-Based Gvhd Prophylaxis, for Prevention of Acute GI Gvhd after Allogeneic Transplantation

Piyanuch Kongtim, Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Deepa Jeyakumar, Benjamin Lee, Jean Doh, Shawn P. Griffin, Richard Van Etten, Stefan O. Ciurea
Journal: Blood
Blood (2024) 144 (Supplement 1): 4908.
https://doi.org/10.1182/blood-2024-202468
Published: 2024
Journal Articles

Fludarabine-Melphalan with Total Body Irradiation or with Thiotepa Conditioning for Adult Patients with Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation

Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Deepa Jeyakumar, Kiran Naqvi, Benjamin Lee, Jean Doh, Shawn P. Griffin, Jeffrey Kuo, Jeremy Harris, Piyanuch Kongtim, Stefan O. Ciurea
Journal: Blood
Blood (2024) 144 (Supplement 1): 7307.
https://doi.org/10.1182/blood-2024-201752
Published: 2024
Journal Articles

Venetoclax Combined with Cladribine, Idarubicin, Cytarabine (CLIA) Results in Higher Remission Rates over Conventional 7+3 Chemotherapy without Increased Toxicity in Newly Diagnosed Acute Myeloid Leukemia

Benjamin J. Lee, Shawn P. Griffin, Jean Doh, Stefan O. Ciurea, Piyanuch Kongtim, Deepa Jeyakumar, Kiran Naqvi
Journal: Blood
Blood (2024) 144 (Supplement 1): 1517.
https://doi.org/10.1182/blood-2024-202856
Published: 2024
Journal Articles

Likelihood of finding an 8/8 HLA-matched unrelated donor (Donor Search Prognosis) is not associated with survival: Primary results from BMT CTN 1702

Stephanie J. Lee, Brent R. Logan, Mary M. Horowitz, Peter Westervelt, William J. Hogan, Joseph A. Pidala, Jason Dehn, Brandon Hayes-Lattin, Nosha Farhadfar, Asad Bashey, Michael R. Grunwald, Samer A. Srour, Claudio Brunstein, Heather Jill Symons, Joseph Uberti, Iskra Pusic, Eric Leifer, Naya He, Steven M. Devine, Bronwen E. Shaw, Stefan O. Ciurea
Journal: Blood
Blood (2024) 144 (Supplement 1): 695.
https://doi.org/10.1182/blood-2024-200833
Published: 2024
Journal Articles

Incidence and Outcomes of Toxoplasma Reactivation in Patients with Hematologic Diseases after Allogeneic Hematopoietic Stem Cell Transplantation

Taha Al-Juhaishi, Alexandre Elias Malek, Denái R. Milton, Jeremy L. Ramdial, May Daher, Amanda L. Olson, Samer A. Srour, Gheath Alatrash, Betul Oran, Rohtesh S. Mehta, Issa F. Khouri, Qaiser Bashir, Nina Shah, Stefan O. Ciurea, Gabriela Rondon, Farzaneh Maadani, Chitra Hosing, David Marin, Partow Kebriaei, Katayoun Rezvani, Yago Nieto, Paolo Anderlini, Amin M. Alousi, Muzaffar H. Qazilbash, Uday R. Popat, Richard E. Champlin, Elizabeth J. Shpall, Victor Mulanovich, Sairah Ahmed
Journal: Blood
Blood (2021) 138 (Supplement 1): 1779.
https://doi.org/10.1182/blood-2021-151474
Published: 2021
Journal Articles

Impact of HLA Molecular Mismatch on Haploidentical Hematopoietic Stem Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study

Jun Zou, Tao Wang, Yung-Tsi Bolon, Shahinaz M. Gadalla, Steven G.E. Marsh, Michelle Kuxhausen, Meilun He, Sophie Paczesny, Stephen R. Spellman, Stephanie J. Lee, Stefan O. Ciurea
Journal: Blood
Blood (2021) 138 (Supplement 1): 3917.
https://doi.org/10.1182/blood-2021-146847
Published: 2021
Journal Articles

A Randomized Study of Pretransplant Conditioning Therapy for AML/MDS with Fludarabine ± Clofarabine and Once Daily IV Busulfan with Allogeneic Hematopoietic Transplantation for AML and MDS

Borje S. Andersson, MD, PhD, Peter Thall, Benigno C. Valdez, PhD, Junsheng Ma, MS, Julianne Chen, Sairah Ahmed, MD, Amin M. Alousi, MD, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Alison Gulbis, Chitra Hosing, MD, Roy B. Jones, MD PhD, Jitesh Kawedia, BPharm, Partow Kebriaei, MD, Steven M. Kornblau, MD, Alan Myers, PharmD, PhD RPh, Betul Oran, MDMS, Katayoun Rezvani, MD PhD, Nina Shah, MD, Elizabeth J. Shpall, MD, Simrit Parmar, MD, MSCI, Uday R. Popat, MD, Yago Nieto, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-142680
Published: 2020
Journal Articles

Long-Term Survival for Myeloma after Autologous Stem Cell Transplantation

Samer A. Srour, MD MS, Qaiser Bashir, MD, Denái R. Milton, MS, Yago Nieto, MD, Rohtesh S. Mehta, MDMPH,MS, Neeraj Saini, MD, Ruby Delgado, Gabriela Rondon, Stefan O. Ciurea, MD, Uday R. Popat, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, Elisabet E. Manasanch, MD, Chitra Hosing, MD, Krina K. Patel, MD, Hans C. Lee, MD, Elizabeth J. Shpall, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-143053
Published: 2020
Journal Articles

Survival Trends in Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplantation

Samer A. Srour, MD MS, Qaiser Bashir, MD, Denái R. Milton, MS, Yago Nieto, MD, Rohtesh S. Mehta, MDMPH,MS, Neeraj Saini, MD, Ruby Delgado, Gabriela Rondon, Chitra Hosing, MD, Stefan O. Ciurea, MD, May Daher, Uday R. Popat, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, Elisabet E. Manasanch, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Elizabeth J. Shpall, MD, Hans C. Lee, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-143196
Published: 2020
Journal Articles

Transplant Outcomes with Fludarabine and Melphalan in High Risk AML Patients By Donor Types

Betul Oran, MDMS, Stefan O. Ciurea, MD, Rohtesh S. Mehta, MDMPH,MS, Amin M. Alousi, MD, Gabriela Rondon, Uday R. Popat, MD, David Marin, May Daher, Jin S. Im, Partow Kebriaei, MD, Gheath Alatrash, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-134474
Published: 2020
Journal Articles

Haploidentical Mbil-21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Multiple Relapsed and Refractory Acute Myeloid Leukemia

Stefan O. Ciurea, MD, Jolie Schafer, Piyanuch Kongtim, MD, Julianne Chen, Doris Soebbing, Kai Cao, MS, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Marina Konopleva, MD PhD, Dean Anthony Lee, MD PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-134858
Published: 2020
Journal Articles

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Brief Report
Stefan O. Ciurea, Piyanuch Kongtim, Ankur Varma, Gabriela Rondon, Julianne Chen, Samer Srour, Qaiser Bashir, Amin Alousi, Rohtesh Mehta, Betul Oran, Uday Popat, Chitra Hosing, Amanda Olson, Naval Daver, Marina Konopleva, Richard E. Champlin
Journal: Blood
Blood (2020) 135 (6): 449–452.
https://doi.org/10.1182/blood.2019003662
Published: 2020
Includes: Supplemental data
Journal Articles

Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation

Fevzi F. Yalniz, Rima M. Saliba, PhD, Orhan K. Yucel, Guillermo Garcia-Manero, MD, Jeremy Ramdial, MD, Uday Popat, MD, Stefan O. Ciurea, MD, Partow Kebriaei, MD, Amin M. Alousi, MD, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Chitra Hosing, MD, David Marin, MD, Rohtesh Mehta, MD, Amanda L. Olson, MD, Katayoun Rezvani, MD PhD, Elizabeth J. Shpall, MD, Gabriela Rondon, MD, Richard E. Champlin, MD, Betul Oran, MDMS
Journal: Blood
Blood (2019) 134 (Supplement_1): 512.
https://doi.org/10.1182/blood-2019-125937
Published: 2019
Journal Articles

Improved Outcomes for Patients Receiving High-Doses of IL-21 Ex Vivo Expanded NK Cells after Haploidentical Transplantation (haploSCT): Long-Term Follow-up of a Phase 1/2 Clinical Trial with Comparison to CIBMTR Controls

Stefan O. Ciurea, MD, Roland Bassett, Doris Soebbing, Gabriela Rondon, MD, Kai Cao, MS, MD, Amanda L. Olson, MD, Qaiser Bashir, MBBS, Elizabeth J. Shpall, MD, Steven Devine, Marcelo C. Pasquini, MD, Andrew St. Martin, MS, Dean Anthony Lee, MD PhD, Richard E Champlin
Journal: Blood
Blood (2019) 134 (Supplement_1): 700.
https://doi.org/10.1182/blood-2019-123936
Published: 2019
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study

Uday Popat, MD, Rohtesh S. Mehta, MD, Roland Bassett, Amanda L. Olson, MD, Julianne Chen, Christina Ganesh, BSN, RN, Amin M. Alousi, MD, Paolo Anderlini, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Stefan O. Ciurea, MD, Chitra Hosing, MD, Jin S Im, MD PhD, Partow Kebriaei, MD, Issa F. Khouri, MD, David Marin, MD, Yago Nieto, MD PhD, Betul Oran, MDMS, Neeraj Saini, MD, Samer Srour, Katayoun Rezvani, MD PhD, Muzaffar Qazilbash, Jeffrey J. Molldrem, Elizabeth J. Shpall, MD, Borje S Andersson, MD PhD, Richard E Champlin
Journal: Blood
Blood (2019) 134 (Supplement_1): 256.
https://doi.org/10.1182/blood-2019-122124
Published: 2019
Journal Articles

A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS

Richard E. Champlin, MD, Uday Popat, MD, Betul Oran, MDMS, Stefan O. Ciurea, MD, Partow Kebriaei, MD, Amin M. Alousi, MD, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Issa F. Khouri, MD, Chitra Hosing, MD, Paolo Anderlini, Roy B Jones, MD PhD, David Marin, MD, Rohtesh Mehta, MD, Yago Nieto, MD PhD, Amanda L. Olson, MD, Muzaffar H. Qazilbash, MD, Katy Rezvani, MD PhD, Elizabeth J. Shpall, MD, Julianne Chen, Gabriela Rondon, MD, Becky McMullin, Vivian P Al Jahdhami, RN, Jitesh Kawedia, BPharm, Benigno C. Valdez, PhD, Junsheng Ma, MS, Peter F Thall, Borje S Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 257.
https://doi.org/10.1182/blood-2019-124921
Published: 2019
Journal Articles

Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantation (ASCT) for Patients (pts) with Relapsed Follicular Lymphoma (FL)

Issa F. Khouri, MD, Denái R. Milton, Celina Ledesma, Loretta J. Nastoupil, MD MSc, Elias Jabbour, MD, Paolo Anderlini, Qaiser Bashir, MBBS, Stefan O. Ciurea, MD, May Daher, MD, Luis E. Fayad, MD, Jin S Im, MD PhD, Swaminathan P. Iyer, MD, David Marin, MD, Rohtesh S. Mehta, MD, Jeffrey J. Molldrem, Amanda L. Olson, MD, Betul Oran, MDMS, Uday Popat, MD, Muzaffar Qazilbash, Samer Srour, Felipe Samaniego, MD, Gabriela Rondon, MD, L. Jeffrey Medeiros, MD, Alison Gulbis, Richard E Champlin
Journal: Blood
Blood (2019) 134 (Supplement_1): 322.
https://doi.org/10.1182/blood-2019-124590
Published: 2019
Journal Articles

Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression

Paul Koller, Rima M. Saliba, PhD, Celina Ledesma, Gabriela Rondon, MD, Uday Popat, MD, Amin M. Alousi, MD, Rohtesh S. Mehta, MD, Betul Oran, MDMS, Amanda L. Olson, MD, Chitra Hosing, MD, Muzaffar H. Qazilbash, MD, Issa F. Khouri, MD, Stefan O. Ciurea, MD, Elizabeth J. Shpall, MD, Jeffrey L. Jorgensen, MD PhD, Sa A Wang, MD, Nitin Jain, MD, Elias Jabbour, MD, Hagop M. Kantarjian, MD, Richard E Champlin, Marina Y Konopleva, MD PhD, Partow Kebriaei, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4598.
https://doi.org/10.1182/blood-2019-130645
Published: 2019
Journal Articles

Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receiving Myeloablative Fractionated Busulfan Conditioning Regimen

Uday Popat, MD, Rima M. Saliba, PhD, Rohtesh S. Mehta, MD, Amanda L. Olson, MD, Julianne Chen, Christina Ganesh, BSN, RN, Gabriela Rondon, MD, Glenda Woodworth, BSN, OCN, RN, Becky McMullin, Amin M. Alousi, MD, Paolo Anderlini, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Stefan O. Ciurea, MD, Chitra Hosing, MD, Jin S Im, MD PhD, Partow Kebriaei, MD, Issa F. Khouri, MD, David Marin, MD, Yago Nieto, MD PhD, Betul Oran, MDMS, Neeraj Saini, MD, Samer Srour, Katayoun Rezvani, MD PhD, Muzaffar H. Qazilbash, MD, Jeffrey J. Molldrem, Elizabeth J. Shpall, MD, Borje S Andersson, MD PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3296.
https://doi.org/10.1182/blood-2019-125996
Published: 2019